AChRbeta2 Antibodies

Santa Cruz Biotechnology offers a broad range of AChRbeta2 monoclonal antibodies for research focused on understanding the acetylcholine receptor beta-2 subunit. AChRbeta2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The AChRbeta2 subunit functions as a key component of the nicotinic acetylcholine receptor, playing an essential role in neurotransmission and muscle contraction. Proper functioning of AChRbeta2 ensures effective neuromuscular signaling, while alterations in its expression can lead to various neurological disorders. Research has shown that AChRbeta2 activity influences synaptic plasticity and cognitive function. Understanding AChRbeta2 mechanisms can provide valuable insights into potential therapeutic approaches for neurological conditions. Investigating AChRbeta2 expression patterns helps reveal its role in both healthy and diseased states. Current studies continue to uncover new aspects of AChRbeta2 function in neural development and maintenance. Santa Cruz Biotechnology monoclonal antibodies for AChRbeta2 support researchers worldwide in advancing our understanding of neurobiology and neurological disease mechanisms.